Insider Transactions in Q2 2021 at Graphite Bio, Inc. (GRPH)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2021
|
Samsara Bio Capital, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
500,000
+17.3%
|
$8,500,000
$17.0 P/Share
|
|
Jun 29
2021
|
Samsara Bio Capital, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,931,623
+36.56%
|
-
|
|
Jun 29
2021
|
Davis Jerel Director |
BUY
Open market or private purchase
|
Indirect |
180,000
+9.54%
|
$3,060,000
$17.0 P/Share
|
|
Jun 29
2021
|
Davis Jerel Director |
BUY
Conversion of derivative security
|
Indirect |
13,871,446
+47.81%
|
-
|
|
Jun 29
2021
|
Versant Venture Capital Vi, L.P. |
BUY
Open market or private purchase
|
Indirect |
180,000
+9.54%
|
$3,060,000
$17.0 P/Share
|
|
Jun 29
2021
|
Versant Venture Capital Vi, L.P. |
BUY
Conversion of derivative security
|
Indirect |
1,527,719
+50.0%
|
-
|
|
Jun 29
2021
|
Versant Venture Capital Vi, L.P. |
BUY
Conversion of derivative security
|
Direct |
12,343,727
+45.63%
|
-
|
|
Jun 29
2021
|
Smital Shah Director |
BUY
Open market or private purchase
|
Indirect |
5,882
+50.0%
|
$99,994
$17.0 P/Share
|
|
Jun 29
2021
|
Joshua Lehrer Graiwer PRESIDENT AND CEO |
BUY
Conversion of derivative security
|
Direct |
8,126
+0.69%
|
-
|
|
Jun 29
2021
|
Perry A Karsen Director |
BUY
Conversion of derivative security
|
Direct |
8,126
+4.72%
|
-
|
|
Jun 29
2021
|
Joseph Jimenez Director |
BUY
Conversion of derivative security
|
Direct |
8,126
+4.78%
|
-
|
|
Jun 29
2021
|
Phil Gutry CHIEF BUSINESS OFFICER |
BUY
Conversion of derivative security
|
Direct |
8,126
+2.69%
|
-
|
|
Jun 29
2021
|
Katherine V Stultz CHIEF OPERATING OFFICER |
BUY
Conversion of derivative security
|
Direct |
8,126
+3.63%
|
-
|
|
Apr 18
2021
|
Phil Gutry CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,383
+1.17%
|
$20,298
$6.11 P/Share
|